Cancer Research

Published by: American Association for Cancer Research  

People

  1. Hudis
    Hudis
  2. Rosen
    Rosen
  3. Morrow
    Morrow
  4. Chaganti
    Chaganti
  5. Modi
    Modi
  6. Norton
    Norton
  7. Chandarlapaty
    Chandarlapaty
  8. Cheung
    Cheung
  9. Giri
    Giri
  10. Joseph
    Joseph

Groups

  1. Department of Medicine (33)
  2. GSK Faculty (30)
  3. Solid Tumor Oncology Division (27)
  4. Sloan Kettering Institute Faculty (23)
  5. Breast Medicine Service (21)
  6. Molecular Pharmacology and Chemistry Program Faculty (17)
  7. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (16)
  8. Survivorship Research (15)
  9. Surgery (13)
  10. Center for Hematologic Malignancies (9)
Search Within
  1. "2010"
  2. "Meeting abstract"
Formats
  1. Meeting Abstract (59)
Groups
  1. Department of Medicine (33)
  2. GSK Faculty (30)
  3. Solid Tumor Oncology Division (27)
  4. Sloan Kettering Institute Faculty (23)
  5. Breast Medicine Service (21)
  6. Molecular Pharmacology and Chemistry Program Faculty (17)

More Groups

People
  1. Clifford Hudis (10)
  2. Neal Rosen (6)
  3. Maura Dickler (5)
  4. Monica Morrow (5)
  5. Tari King (5)
  6. Victor Andrade (5)

More People

Years
  1. 2010 (59)
Publishers
  1. American Association for Cancer Research (59)

Results (59)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Gene expression profiling identifies potential precursor genes in lobular carcinoma in situ
    Meeting Abstract

    Andrade, V. P.; Morrogh, M.; Qin, L. X.; Olvera, N.; Giri, D.; Brogi, E.; de Alcantara- Filho, P.; Paik, W.; Muhsen, S.; Morrow, M.; more...
    Cancer Research (2010)

    Fulltext@MSK | Save
  • CALGB 40302: Fulvestrant with or without lapatinib as therapy for hormone receptor positive advanced breast cancer: A double-blinded, placebo-controlled, randomized phase III study
    Meeting Abstract

    Burstein, H. J.; Barry, W. T.; Cirrincione, C.; Chew, H. K.; Tolaney, S.; Lake, D.; Pluard, T.; Blackwell, K.; Winer, E. P.; Hudis, C. A.
    Cancer Research (2010)

    Fulltext@MSK | Save
  • Administration of the novel antiangiogenic PTC299 in combination with aromatase inhibitors is feasible and shows antitumor activity in metastatic breast cancer
    Meeting Abstract

    Tiersten, A.; Schneider, B. P.; Dickler, M.; Volm, M.; Speyer, J.; Novik, Y.; Lehman, R.; Callahan, L. A.; Darby, C. H.; Miller, L. L.; more...
    Cancer Research (2010)

    Fulltext@MSK | Save
  • Combination of tivozanib, an oral inhibitor of VEGFR, with weekly paclitaxel for metastatic breast cancer: Preliminary results of an ongoing phase 1 study
    Meeting Abstract

    Mayer, E. L.; Scheulen, M.; Beckman, J.; Richly, H.; Poli, A.; Bhargava, P.; Duarte, A.; Cotreau, M.; Al-Adhami, M.; Dickler, M.
    Cancer Research (2010)

    Fulltext@MSK | Save
  • Clonal relatedness between lobular carcinoma in situ and synchronous malignant lesions: Analysis of fresh frozen tissue using SNP array
    Meeting Abstract

    Andrade, V. P.; Morrogh, M.; Giri, D.; Ostrovnaya, I.; Seshan, V.; Olvera, N.; Begg, C.; Morrow, M.; King, T. A.
    Cancer Research (2010)

    Fulltext@MSK | Save
  • Phase 1 dose-escalation study of the heat shock protein 90 inhibitor BIIB021 with trastuzumab in HER2+ metastatic breast cancer
    Meeting Abstract

    Modi, S.; Ismail-Khan, R.; Munster, P.; Lucas, M.; Galluppi, G. R.; Tangri, S.; Chen, Y.; Yamashita, M.; Storgard, C. M.; Moulder, S.
    Cancer Research (2010)

    Fulltext@MSK | Save
  • A dose-escalation study of trastuzumab-DM1 (T-DM1), paclitaxel (T), and pertuzumab (P) in patients with HER2-positive, locally advanced or metastatic breast cancer (MBC) previously treated with a trastuzumab-containing regimen
    Meeting Abstract

    Krop, I. E.; Modi, S.; Elias, A.; LoRusso, P.; Choi, Y. J.; Lu, M.
    Cancer Research (2010)

    Fulltext@MSK | Save
  • Pharmacokinetics (PK) of trastuzumab-DM1 (T-DM1) and paclitaxel (T) in patients with HER2-positive locally advanced or metastatic breast cancer (MBC) previously treated with a trastuzumab-containing regimen
    Meeting Abstract

    Lu, D.; Krop, I.; Modi, S.; Elias, A.; LoRusso, P.; Huang, J.; Lu, M.; Girish, S.
    Cancer Research (2010)

    Fulltext@MSK | Save
  • Late toxicity and patient self-assessment of breast appearance/satisfaction on RTOG 0319: A phase II trial of three dimensional conformal radiation therapy (3DCRT) partial breast irradiation (PBI) following lumpectomy for stage I and II breast cancer
    Meeting Abstract

    Chafe, S. J.; Moughan, J.; Vicini, F. A.; Wong, J. W. C.; Pass, H. A.; Rabinovich, R. A.; Arthur, D. W.; Petersen, I. A.; White, J. R.; McCormick, B.
    Cancer Research (2010)

    Fulltext@MSK | Save
  • Symptomatic congestive heart failure after neo/adjuvant dose-dense epirubicin: A retrospective analysis of two trials with long-term follow-up
    Meeting Abstract

    Gajria, D.; Pokuri, V.; Steingart, R.; Hudis, C.; Dang, C.
    Cancer Research (2010)

    Fulltext@MSK | Save

    • Cancer Research – authorized name for:

    Name ISSN / ISBN Publisher
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 15387445 American Association for Cancer Research
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 00085472 American Association for Cancer Research
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 00085472 American Association Tor Cancer Research
    Cancer Research 00085472 American Association for Cancer Research
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 0008-5472 Unknown
    Cancer research 15387445 The Authors the American Association for Cancer Research
    Cancer Research 00085472 American Association for Cancer Research
    Cancer Research 15387445 American Association for Cancer Research
    Cancer research 15387445 American Association for Cancer Research
    Cancer Research 00085472 Unknown
    Cancer Research 00085472 American Association for Cancer Research
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer research 15387445 Unknown
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 00085472 American Association for Cancer
    Cancer Research 00085472 The Authors
    Cancer Research 00085472 The Authors the American Association for Cancer Research